We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Problem-Solving Strategy Depends on Estrogen Levels

By Biotechdaily staff writers
Posted on 09 Jun 2002
Investigators have found that activation of different parts of the brain may depend on the presence or absence of estrogen. More...
A study on the effect of the hormone or its lack on rat learning behavior appears in the June 2002 issue of Behavioral Neuroscience.

Results from previous studies on rats were difficult to interpret, as the rats were forced to cope with stress as well as learn new tasks. The current studies were carried out using positive-reward, food-based tests in order to remove stress from the equation.

Two different types of tasks were studied: a place-learning task, where the food was always in the same place, and a response-learning task, where a new route to the food had to be learned. The ovaries were removed from the rats to decrease circulating estrogen levels. One group then had estrogen levels raised by injections of the hormone.

In the place-training test, food always was at the same place, but the required turn in the maze changed, depending on the rats' starting point. Rats on estrogen learned the task faster than the untreated group. For the response-training test, the rats always found food by turning right (or left) at the first opportunity regardless of where they had started. Rats without estrogen learned this task quicker than the estrogen-treated ones.

"What we found is that given these analogous tasks that require different cognitive strategies, estrogen biased the rats to use a place, or spatial, strategy,” said Dr. Donna L. Korol, of the University of Illinois (Urbana-Champaign, USA). "Those not given estrogen are better using a response, or non-spatial, strategy. This suggests that estrogen is not good for all kinds of memory. Rather, it is very specific in dictating what strategy one takes. Estrogen may enhance some and impair other forms of learning.”

The researchers extrapolated their findings in rats to suggest that they may mimic the situation in postmenopausal women. "A postmenopausal woman not on HRT [hormone replacement therapy] may believe that her ability to solve a problem as she always had is slipping. In reality, the brain may be shifting gears into a different strategy that the woman is not used to harnessing,” Korol said.



Related Links:
University of Illinois

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.